SANUWAVE Health (OTCMKTS:SNWV – Get Free Report) and Beauty Health (NASDAQ:SKIN – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, valuation, risk, analyst recommendations, institutional ownership, earnings and profitability.
Insider & Institutional Ownership
42.5% of SANUWAVE Health shares are held by institutional investors. Comparatively, 93.3% of Beauty Health shares are held by institutional investors. 36.6% of SANUWAVE Health shares are held by insiders. Comparatively, 41.0% of Beauty Health shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares SANUWAVE Health and Beauty Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| SANUWAVE Health | -1.33% | -23.83% | -20.60% |
| Beauty Health | -8.11% | -44.83% | -3.54% |
Analyst Ratings
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| SANUWAVE Health | 0 | 0 | 0 | 0 | 0.00 |
| Beauty Health | 1 | 3 | 1 | 0 | 2.00 |
Beauty Health has a consensus price target of $2.55, indicating a potential upside of 95.40%. Given Beauty Health’s stronger consensus rating and higher probable upside, analysts clearly believe Beauty Health is more favorable than SANUWAVE Health.
Valuation & Earnings
This table compares SANUWAVE Health and Beauty Health”s top-line revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| SANUWAVE Health | $20.40 million | 11.77 | -$25.81 million | $8.32 | 3.38 |
| Beauty Health | $347.62 million | 0.47 | -$100.12 million | ($0.42) | -3.11 |
SANUWAVE Health has higher earnings, but lower revenue than Beauty Health. Beauty Health is trading at a lower price-to-earnings ratio than SANUWAVE Health, indicating that it is currently the more affordable of the two stocks.
Volatility & Risk
SANUWAVE Health has a beta of 1.23, meaning that its share price is 23% more volatile than the S&P 500. Comparatively, Beauty Health has a beta of 0.82, meaning that its share price is 18% less volatile than the S&P 500.
About SANUWAVE Health
SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company's pulsed acoustic cellular expression systems, including dermaPACE system for treating diabetic foot ulcers and other chronic wounds; orthoPACE system for treating tendinopathies and acute and nonunion fractures; and Profile is used to provide solution for pain management in sports medicine and physical therapy. Its portfolio of wound treatment solutions provides patients with a noninvasive technology that boosts the body's normal healing and tissue regeneration processes. In addition, the company offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds. SANUWAVE Health, Inc. was founded in 2004 and is headquartered in Eden Prairie, Minnesota.
About Beauty Health
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Receive News & Ratings for SANUWAVE Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SANUWAVE Health and related companies with MarketBeat.com's FREE daily email newsletter.
